Cited by 585Schizophrenia research and treatmentPsychopathy, Forensic Psychiatry, Sexual OffendingBipolar Disorder and Treatment

EPA guidance on the early intervention in clinical high risk states of psychoses

Schmidt, S.J., Schultze-Lutter, F., Schimmelmann, B.G., Maric, N.P., Salokangas, R.K.R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A. +6 more·2015·European Psychiatry

Abstract

This guidance paper from the European Psychiatric Association (EPA) aims to provide evidence-based recommendations on early intervention in clinical high risk (CHR) states of psychosis, assessed according to the EPA guidance on early detection. The recommendations were derived from a meta-analysis of current empirical evidence on the efficacy of psychological and pharmacological interventions in CHR samples. Eligible studies had to investigate conversion rate and/or functioning as a treatment outcome in CHR patients defined by the ultra-high risk and/or basic symptom criteria. Besides analyses on treatment effects on conversion rate and functional outcome, age and type of intervention were examined as potential moderators. Based on data from 15 studies ( n = 1394), early intervention generally produced significantly reduced conversion rates at 6- to 48-month follow-up compared to control conditions. However, early intervention failed to achieve significantly greater functional improvements because both early intervention and control conditions produced similar positive effects. With regard to the type of intervention, both psychological and pharmacological interventions produced significant effects on conversion rates, but not on functional outcome relative to the control conditions. Early intervention in youth samples was generally less effective than in predominantly adult samples. Seven evidence-based recommendations for early intervention in CHR samples could have been formulated, although more studies are needed to investigate the specificity of treatment effects and potential age effects in order to tailor interventions to the individual treatment needs and risk status.

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2015.01.013

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Indicated prevention approaches have shown potential to reduce subclinical symptoms or prevent onset of a mental disorder in help-seeking and community samples.

    “Indicated prevention approaches have shown the potential to reduce subclinical symptoms or even prevent the onset of a mental disorder in help-seeking and community samples [28–31]”
  • NICE guidelines prohibit prophylactic antipsychotic treatment, while EPA guidelines allow its use for severe and progressive symptomatology.

    “However, while prophylactic treatment with antipsychotics is altogether prohibited by NICE guidelines 9 , the EPA allows its use in the case of severe and progressive symptomatology 10 .”
  • Previous pairwise meta-analyses in this field had methodological limitations, including heterogeneous interventions, non-standard clinical high risk samples, non-randomized trials, pooling of time-dependent outcomes, and poor meta-analytical approaches.

    “The other meta-analyses were affected by mistakes 19 or methodological limitations”
  • Current international guidelines recommend that clinical high risk for psychosis individuals be primarily offered cognitive behavioural therapy with or without family interventions.

    “Current international guidelinessuch as those of the National Institute for Health and Care Excellence (NICE) and the European Psychiatric Association (EPA) -recommend that CHR-P individuals be primarily offered cognitive behavioural therapy (CBT) with or without family interventions 9,10 .”
  • Evidence converges on a lack of significant benefit for clinical outcomes other than transition to psychosis, including attenuated symptom severity, functioning, depressive comorbidities, distress and quality of life.

    “There is also converging lack of significant benefits on other clinical outcomes besides transition to psychosis, such as attenuated symptom severity 14,15,96 , functioning 10,14,18 , depressive comorbidities 15 , distress 14 , and quality of life 14,15 .”

The citation lists haven’t been fetched yet

References 233 · Cited by 585

Authors
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A., Nordentoft, M., Marshall, M., Morrison, A., Raballo, A., Klosterkötter, J., & Ruhrmann, S.
Affiliations
  • University of Bern (CH)
  • University of Turku (FI)
  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
  • University of Copenhagen (DK)
  • University of Manchester (GB)
  • Regione Emilia-Romagna (IT)
  • University of Cologne (DE)
Corresponding author
Klosterkötter, J.
Venue
European Psychiatry
Published
2015-03
Volume
30
Issue
3
Pages
388-404
ISSN
  • 0924-9338 (ISSN-L)
  • 1778-3585
OpenAlex
W2024654275
Cited by
585
References
233
Citations by year
2026: 18 · 2025: 37 · 2024: 51 · 2023: 43 · 2022: 33 · 2021: 63 · 2020: 76 · 2019: 78 · 2018: 64 · 2017: 61 · 2016: 42 · 2015: 18 · 2014: 1
FWCI
50.10
Type
journal article
Language
en
Open access
closed
Locations
  • European Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • edoc (University of Basel) (acceptedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • VU Research Portal (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
Lundbeckfonden (R155-2014-1724)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
early intervention, psychosis, clinical high risk for psychosis, transition to psychosis, functional outcome, psychological intervention, pharmacological interventions, early detection, youth, age effects, treatment guidelines
MeSH terms
Adolescent, Adult, Humans, Male, Psychiatric Status Rating Scales, Psychotic Disorders, Risk Factors, Schizophrenia, Antipsychotic Agents, Treatment Outcome, Practice Guidelines as Topic, Mood Disorders, Early Diagnosis, Early Medical Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review